Abstract |
4-S-cysteinylphenol (4-S-CP), the S-homologue of tyrosine, has been recently synthesized as a selective chemotherapeutic agent against malignant melanoma and has been shown to be a specific substrate for tyrosinase in vitro. In vivo incorporation of 4-S-CP into the B16 and Harding Passey (HP) melanomas and the systemic organs have been evaluated by the autoradiographic method. The distribution of the silver grains indicated that 4-S-CP was selectively incorporated into both the B16 and HP melanomas. 4-S-CP was excreted mainly from the kidneys and there was an accumulation of 4-S-CP in the reticulo-endothelial system. These results seemed to contribute to the utilization of 4-S-CP and other related compounds as chemotherapeutic agents against malignant melanoma.
|
Authors | T Nakamura, O Matsubara, T Kasuga, J Suzuki, K Ishikawa, S Ito |
Journal | The Bulletin of Tokyo Medical and Dental University
(Bull Tokyo Med Dent Univ)
Vol. 34
Issue 4
Pg. 93-8
(Dec 1987)
ISSN: 0040-8921 [Print] Japan |
PMID | 3327627
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- 4-S-cysteinylphenol
- Cysteine
|
Topics |
- Animals
- Antineoplastic Agents
(analysis, pharmacokinetics)
- Bone Marrow
(metabolism)
- Brain
(metabolism)
- Cysteine
(analogs & derivatives, analysis, pharmacokinetics)
- Epidermis
(metabolism)
- Histological Techniques
- Kidney Tubules
(metabolism)
- Liver
(metabolism)
- Melanoma, Experimental
(analysis, metabolism)
- Mice
- Mice, Inbred C57BL
- Spleen
(metabolism)
|